Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
スポンサーリンク
概要
著者
-
Yokozawa Toshiya
豊橋市民病院 血液･腫瘍内科
-
Yokozawa T
Nagoya Univ. Graduate Schol Of Medicine Nagoya Jpn
-
Yokozawa T
Hematology Division National Cancer Center Hospital
-
ANDO Kiyoshi
Tokai University
-
Okada Masaya
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Okada Masaya
兵庫医科大学 総合内科
-
Okada Masaya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Kanamaru A
Department Of Hematology Kinki University School Of Medicine
-
Okada Masaya
Hyogo Coll. Medicine Nishinomiya Jpn
-
KANAMARU Akihisa
Third Department of Internal Medicine, Kinki University School of Medicine
-
OKAMOTO Takahiro
Second Department of Internal Medicine, Hyogo College of Medicine
-
TAKEMOTO Yoshinobu
Second Department of Internal Medicine, Hyogo College of Medicine
-
Takemoto Y
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Takemoto Yoshinobu
Department Of Pathology Okayama University Medical School
-
Okamoto T
Second Department Of Internal Medicine Hyogo College Of Medicine
-
MORI Ako
Second Department of Internal Medicine, Hyogo College of Medicine
-
SAHEKI Kaname
Second Department of Internal Medicine, Hyogo College of Medicine
-
OKADA Masaya
Second Department of Internal Medicine, Hyogo College of Medicine
-
KAKISHITA Eizo
Second Department of Internal Medicine, Hyogo College of Medicine
-
TAKATSUKA Hiroyuki
Second Department of Internal Medicine, Hyogo College of Medicine, Hyogo
-
FUJIMORI Yoshihiro
Second Department of Internal Medicine, Hyogo College of Medicine, Hyogo
-
TAMURA Shu
Second Department of Internal Medicine, Hyogo College of Medicine, Hyogo
-
WADA Hiroshi
Second Department of Internal Medicine, Hyogo College of Medicine, Hyogo
-
NAGAI Kiyoyasu
Second Department of Internal Medicine, Hyogo Colege of Medicine
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Kanamaru Akihisa
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Nagai Kazuhiro
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Nagai Kazuhiro
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
岡田 昌也
兵庫医科大学病院血液内科
-
Okamoto Takahiro
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Wada Hiroshi
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Yoshino Tadashi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
TAKATSUKA Hiroyuki
Koito Manufacturing Co. Ltd
-
Takemoto Yoshinobu
Department Of Pathology Okayama University
-
Takatsuka Hiroyuki
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Mori Ako
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Tamura Shu
Second Department Of Internal Medicine Hyogo College Of Medicine Hyogo
-
Kikuchi Ako
Department Of Hematology/oncology Tokai University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Saheki Kaname
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Nagai Kiyoyasu
Second Department Of Internal Medicine Hyogo Colege Of Medicine
-
Kakishita E
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Kakishita Eizo
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Takemoto Yoshinobu
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Fujimori Yoshihiro
Laboratory Of Cell Transplantation Institute Of Advanced Medical Sciences Hyogo College Of Medicine
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Yoshino Tadashi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- 9年後対側に再発した異時性両側精巣悪性リンパ腫の1例
- 同種骨髄移植後のhuman herpes virus-6血症患者に発症したbronchioltis obliterans organizing pneumonia (BOOP)様肺病変
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- 小児および成人造血器悪性腫瘍に対する非血縁さい帯血移植の比較検討
- Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- 同種骨髄移植における GVHD 予防法の検討
- 骨髄移植後の気管支肺胞洗浄液におけるリンパ球CD4/CD8比とサイトメガロウイルス感染との関連性
- 骨髄移植とサイトメガロウイルス感染 : 感染の危険因子
- 非血縁者間骨髄移植におけるCMV感染とpre - emptive therapy
- 骨髄移植患者における気管支肺胞洗浄液を用いたサイトメガロウイルス抗原検索によるCMV感染のモニタリングに関する検討
- Cyclophosphamideとウサギ抗ヒト胸腺細胞免疫グロブリンの前処置にて緊急に骨髄移植を施行した肺炎合併の重症再生不良性貧血
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- P2-163 ラジオアイソトープ標識抗体療法剤ゼヴァリン^[○!R]イットリウムによる血球減少の調査(一般演題 ポスター発表,有害事象・副作用,臨床から学び臨床へと還元する医療薬学)
- Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
- A duodenal follicular lymphoma associated with the lesion mimicking MALT lymphoma in terminal ileum and Bauhin valve
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Mechanisms of retinoid resistance in a myeloid cell line, YM711,transfected with PML/RARα cDNA : possible involvement of redox potential
- Reduced-Intensity Conditioning Followed by Unrelated Umbilical Cord Blood Transplantation for Advanced Hematologic Malignancies : Rapid Engraftment in Bone Marrow
- Secondary Acute Promyelocytic Leukemia in a Patient With Non-Hodgkin's Lymphoma Treated With VP-16 and MST-16
- The Role of Screening Bronchoalveolar Lavage in BMT Patients
- Changes in Microbial Flora in Neutropenic Patients With Hematological Disorders After the Hanshin-Awaji Earthquake
- High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan
- Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation
- Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
- Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes
- Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
- Detection of donor-type alveolar macrophages in transplantation with highly purified CD34^+ bone marrow cells
- Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Relationships between Hematological Recovery and Overall Survival in Older Adults Undergoing Allogeneic Bone Marrow Transplantation
- Forum 第31回日本造血細胞移植学会ランチョンセミナー Ph[+]白血病に対する新規チロシンキナーゼ阻害薬ダサチニブの治療戦略
- Extramedullary Blast Crisis Derived from 2 Different Clones in the Central Nervous System and Neck during Complete Cytogenetic Remission of Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
- Follicular Lymphoma in Osaka, Japan : Histological Features and Chronological Change
- A Case of Hypoplastic Chronic Myelogenous Leukemia Initiating With Pancytopenia
- Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
- Ex Vivo Expansion of Human Cord Blood Stem Cells and Its Application to Gene Therapy
- A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker
- Possible involvement of the TGF-β1 signal in the development of peritoneal sclerosis as one of the major complications in continuous ambulatory peritoneal dialysis
- Serum KL-6 Levels in Patients With Pulmonary Complications After Allogeneic Bone Marrow Transplantation
- Positron Emission Tomography/Computed Tomography after Immunocytochemical and Clonal Diagnosis of Intraocular Lymphoma with Vitrectomy Cell Blocks
- Detection of ETV6/MDS1/Evi-1 Chimeric Transcripts in a Patient With Acute Myelocytic Leukemia and t(3;12)(q26;p13)
- Ikk-i, a novel Lipopolysaccharide-inducible kinase that is realted to lκB Kinases
- The revised Japanese clinical diagnostic criteria for chronic pancreatitis
- Expression of the Antiapoptosis Gene Survivin in Human Leukemia
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Eosinophilic Colitis in a Patient with Acute Myeloid Leukemia after Allogeneic Bone Marrow Transplantation
- イマチニブに対して Late Suboptimal Response を示した慢性期CML症例に対する治療選択
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis
- Can bone marrow transplantation give the gift of a baby?
- PREDICTIVE VALUE OF ENDOSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY FOR REGRESSION OF GASTRIC DIFFUSE LARGE B-CELL LYMPHOMAS AFTER HELICOBACTER PYLORI ERADICATION
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behcet's disease
- 座談会 濾胞性リンパ腫に対する治療戦略
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- 重篤な鼻出血から診断されたアグレッシブNK細胞白血病例
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
- Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation